NDAINJECTIONINJECTABLE
Approved
Jun 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYDROCORTONE is a corticosteroid injection containing hydrocortisone sodium phosphate, approved since 1960 for acute inflammatory and allergic conditions. Administered via injection, it provides rapid systemic anti-inflammatory and immunosuppressive effects. It is a foundational glucocorticoid used across multiple acute care settings.
LOE Approaching
As a legacy injectable corticosteroid approaching loss of exclusivity, this product operates with minimal commercial investment and a likely contraction in team size.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HYDROCORTONE as a legacy injectable corticosteroid offers limited career advancement opportunity; roles focus on maintaining hospital relationships and managing declining market share. This assignment is typically a stepping stone or stability position rather than a growth engine for career progression.
Brand ManagerField Sales Representative
Worked on HYDROCORTONE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.